Resistant hypertension is a state of excess MR activation in many instances, as judged by volume expansion17 and response to a MR antagonist.18 This MR antagonist responsiveness is not limited to patients with primary aldosteronism. This evidence concerns the gene NR3C2 and primary aldosteronism.